Health Care & Life Sciences » Biotechnology | Organovo Holdings Inc.

Organovo Holdings Inc. | Ownership

Companies that own Organovo Holdings Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
ARK Investment Management LLC
14,860,438
13.1%
3,614,856
0.63%
06/30/2018
BlackRock Fund Advisors
6,438,569
5.68%
787,797
0%
06/30/2018
The Vanguard Group, Inc.
4,508,691
3.97%
151,189
0%
06/30/2018
SSgA Funds Management, Inc.
1,599,387
1.41%
34,832
0%
06/30/2018
Renaissance Technologies LLC
1,244,600
1.1%
798,800
0%
06/30/2018
Geode Capital Management LLC
1,198,304
1.06%
227,104
0%
06/30/2018
Northern Trust Investments, Inc.
1,156,849
1.02%
-40,436
0%
06/30/2018
UBS Securities LLC
838,348
0.74%
187,985
0%
06/30/2018
Charles Schwab Investment Management, Inc.
468,632
0.41%
15,863
0%
06/30/2018
BlackRock Investment Management LLC
349,588
0.31%
1,058
0%
06/30/2018

About Organovo Holdings

View Profile
Address
6275 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.organovo.com
Updated 07/08/2019
Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions.